1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Compliance Monitoring: new trials by email Literature Review of Compliance Monitoring trials Research Report on Compliance Monitoring
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Behavioral Dietary Intervention, Compliance Monitoring, Counseling - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Unknown | Gynecologic Oncology Group | 1070 | 2012-06-18 | 2018-02-19 |
| Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis - Acute Lymphoblastic Leukemia | Phase 3 | Completed | Children's Oncology Group | 570 | 2012-02-21 | 2026-07-31 |
Brenner Tumor (1) · Fallopian Tube Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Children's Oncology Group (1) · Gynecologic Oncology Group (1)
United States (2) · Puerto Rico (1)
David Alberts (1) · Smita Bhatia (1)
PMID 27394382, PMID 32852553, PMID 36608382
R01CA174683 (1), U10CA095861 (1), U10CA101165 (1), U10CA180830 (1), UG1CA189867 (1), UG1CA189955 (1)